Protara Therapeutics, Inc.
TARA· Nasdaq
TARAProtara Therapeutics, Inc.
Filed May 13, 2026 · 10-Q · 43 days after period end · 0001213900-26-055463
| Metric | Q1 2026 | Q1 2025 | Q1 2024 | Q1 2023 |
|---|---|---|---|---|
| Net Income | -$17.78M | -$11.91M | -$11.10M | -$9.05M |
| EPS Diluted | -$0.31 | -$0.29 | -$0.97 | -$0.80 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Protara Therapeutics, Inc. · CIK 1359931 · Engraved from SEC EDGAR
ended Mar 31, 2026 · filed May 13, 2026 · 43 d after period end
